{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:22:20Z","timestamp":1761517340997,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1999,5,1]],"date-time":"1999-05-01T00:00:00Z","timestamp":925516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[1999,5]]},"DOI":"10.4158\/ep.5.3.139","type":"journal-article","created":{"date-parts":[[2013,4,5]],"date-time":"2013-04-05T23:33:41Z","timestamp":1365204821000},"page":"139-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tumor-Grade Hyperprolactinemia Induced by Multiple Medications in The Setting of Renal Failure"],"prefix":"10.1016","volume":"5","author":[{"given":"Konstantinos","family":"Ziambaras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel","family":"Dagogo-Jack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP.5.3.139_bb0005","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJM197801262980408","article-title":"Prolactin","volume":"298","author":"Frantz","year":"1978","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.5.3.139_bb0010","series-title":"Williams Textbook of Endocrinology","first-page":"221","article-title":"The anterior pituitary","author":"Thorner","year":"1992"},{"key":"10.4158\/EP.5.3.139_bb0015","series-title":"Principles and Practice of Endocrinology and Metabolism","first-page":"140","article-title":"Prolactin and its disorders","author":"Katznelson","year":"1995"},{"key":"10.4158\/EP.5.3.139_bb0020","first-page":"737","article-title":"Neuroleptic-associated hyperprolactinemia: can it be treated with bromocriptine?","volume":"37","author":"Smith","year":"1992","journal-title":"J Reprod Med."},{"key":"10.4158\/EP.5.3.139_bb0025","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1146\/annurev.pa.28.040188.002023","article-title":"Neuroleptics and neuroendocrine function","volume":"28","author":"Gunnet","year":"1988","journal-title":"Annu Rev Pharmacol Toxicol."},{"key":"10.4158\/EP.5.3.139_bb0030","first-page":"29","article-title":"Serial plasma prolactin levels in neuroleptic-induced galactorrhea: a case report","volume":"49","author":"Gioia","year":"1988","journal-title":"J Clin Psychiatry."},{"key":"10.4158\/EP.5.3.139_bb0035","first-page":"2342","article-title":"Some forms of big big prolactin behave as a complex of monomeric prolactin with an immunoglobulin G in patients with macroprolactinemia or prolactinoma","volume":"80","author":"Cavaco","year":"1995","journal-title":"J Clin Endocrinol Metab."},{"key":"10.4158\/EP.5.3.139_bb0040","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0002-9343(85)90448-6","article-title":"Macro-prolactinemia presenting like a pituitary tumor","volume":"78","author":"Jackson","year":"1985","journal-title":"Am J Med."},{"key":"10.4158\/EP.5.3.139_bb0045","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJM199004123221502","article-title":"Improvement of gastric emptying in diabetic gastroparesis by erythromycin: preliminary studies","volume":"322","author":"Janssens","year":"1990","journal-title":"N Engl J Med."},{"key":"10.4158\/EP.5.3.139_bb0050","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1471-0528.1976.tb00880.x","article-title":"Follicle stimulating hormone, thyrotrophin, human growth hormone and prolactin in hyperemesis gravidarum","volume":"83","author":"Ylikorkala","year":"1976","journal-title":"Br J Obstet Gynaecol."},{"key":"10.4158\/EP.5.3.139_bb0055","first-page":"212","article-title":"Renal metabolism of peptide hormones","volume":"9","author":"Rabkin","year":"1983","journal-title":"Miner Electrolyte Metab."},{"key":"10.4158\/EP.5.3.139_bb0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.1978.tb02206.x","article-title":"Hyperprolactinaemia in renal disease","volume":"9","author":"Cowden","year":"1978","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP.5.3.139_bb0065","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/0002-9343(80)90296-X","article-title":"Endocrine abnormalities in patients undergoing long-term hemodialysis: the role of prolactin","volume":"68","author":"Gomez","year":"1980","journal-title":"Am J Med."},{"key":"10.4158\/EP.5.3.139_bb0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0272-6386(85)80181-5","article-title":"Hyperprolactinemia in patients with renal insufficiency and chronic renal failure requiring hemodialysis or chronic ambulatory peritoneal dialysis","volume":"6","author":"Hou","year":"1985","journal-title":"Am J Kidney Dis."},{"issue":"1 Pt 1","key":"10.4158\/EP.5.3.139_bb0075","first-page":"E96","article-title":"Mechanism of verapamil calcium channel blockade-induced hyperprolactinemia","volume":"270","author":"Kelley","year":"1996","journal-title":"Am J Physiol."},{"year":"1998","series-title":"Physicians' Desk Reference","key":"10.4158\/EP.5.3.139_bb0080"},{"key":"10.4158\/EP.5.3.139_bb0085","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1365-2265.1984.tb03438.x","article-title":"Oral contraceptive agents do not affect serum prolactin in normal women","volume":"20","author":"Davis","year":"1984","journal-title":"Clin Endocrinol (Oxf)."},{"key":"10.4158\/EP.5.3.139_bb0090","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0889-8529(18)30234-2","article-title":"Hyperprolactinemia: evaluation and management","volume":"21","author":"Blackwell","year":"1992","journal-title":"Endocrinol Metab Clin North Am."}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2041403X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X2041403X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/A3E0JJBH9HA242Q0.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:17:19Z","timestamp":1761517039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X2041403X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,5]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,5]]}},"alternative-id":["S1530891X2041403X"],"URL":"https:\/\/doi.org\/10.4158\/ep.5.3.139","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[1999,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-Grade Hyperprolactinemia Induced by Multiple Medications in The Setting of Renal Failure","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP.5.3.139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1999 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}